Dr. Robert A. Nagourney, MD
Hitting Cancer True and Straight: the Role of Tissue Analysis
Although she showed some response, her disease persisted and she was being considered for surgery to remove the residual tumor...
top of page
Cancer Blog
- Dr. Robert Nagourney -
Search
Dr. Robert A. Nagourney, MD
- Sep 26
- 2 min
Your Cancer Cure May Already Exist
Personalized treatment means more cured patients. More people survive cancer when our Functional Profiling system is used before treatment.
Dr. Robert A. Nagourney, MD
- Aug 30
- 2 min
Pancreatic Cancer Surgery: Know What You Have Consented To!
However, a new dilemma has arisen; the failure of surgeons to comply with Pancreatic Cancer patient’s wishes to have tissue submitted.
Dr. Robert A. Nagourney, MD
- Aug 14
- 3 min
“New” Immune Therapy Active in Late-Stage Cancer Patients
Here in 2023, we
suddenly discover that TIL cells are highly active against cancer, but it was Steven Rosenberg who first described it.
Dr. Robert A. Nagourney, MD
- Jul 24
- 2 min
Stage 4 Cancer Patient Survivals: The Data Is In and It’s Not Good
There has been talk of improved survival in cancer, most progress has reflected screening, early diagnosis, improved staging, and support.
Dr. Robert A. Nagourney, MD
- Jun 26
- 3 min
Challenging Paradigms: The Management of Rectal Cancer
One noteworthy case was a 78-year-old patient successfully treated without surgery.
Dr. Robert A. Nagourney, MD
- Jun 2
- 2 min
Breakthrough for Young Patients with a Rare Form of Liver Cancer
Extremely rare liver cancer that mostly affects people in their twenties associated with a gene rearrangement, mostly lethal, until now.
Dr. Robert A. Nagourney, MD
- May 19
- 3 min
For Medical Oncology, Déjà Vu All Over Again
Patients are being encouraged to contact the researchers to get biopsies and help take charge of their disease.
Dr. Robert A. Nagourney, MD
- May 15
- 4 min
Nagourney Cancer Institute: 20-year Experience in 10,000 Patients
At the 2023 American Association for Cancer Research meeting in Orlando, we reported results of ex vivo analysis of programmed cell death.
Dr. Robert A. Nagourney, MD
- Dec 30, 2022
- 2 min
A Year-End Reflection
2022 Reflection. Among our most important accomplishments in 2022 was the installation of a world-class Mass Spectrometry research program.
Dr. Robert A. Nagourney, MD
- Dec 4, 2013
- 3 min
Gastric (Stomach) Cancer: A Call for Patient Selection
Gastric (stomach) cancer is the fourth most common cancer worldwide with more than 930,000 diagnoses and 800,000 deaths attributed to...
Dr. Robert A. Nagourney, MD
- Oct 20, 2013
- 4 min
The Information Disconnect - Genomics vs Human Cancer Biology
I recently had an interesting conversation with a physician regarding her patient with an aggressive breast cancer. A portion of tumor...
Dr. Robert A. Nagourney, MD
- Jul 8, 2013
- 3 min
Functional Profiling Identifies Accurate Genomic Findings
The 2013 American Society of Clinical Oncology annual meeting, held May 31 – June 1, in Chicago, afforded the opportunity to report three...
Dr. Robert A. Nagourney, MD
- May 19, 2013
- 2 min
Personalized Cancer Care: N-of-1
The New York Yankees catcher Yogi Berra famous quote, “Déjà vu all over again,” reminds me of the growing focus on the concept of “N-...
Dr. Robert A. Nagourney, MD
- Apr 24, 2013
- 3 min
The Future of Cancer Research
The American Association for Cancer Research meeting held April 6 - 10 in Washington DC, provided a scientific perspective on oncologic...
Dr. Robert A. Nagourney, MD
- Apr 18, 2013
- 1 min
Cancer as a Metabolic Disorder
I received an inquiry via Twitter “Has anyone thought about using a sugar medium (similar to PET scans) to deliver chemo drugs?” Although...
bottom of page